大麻二酚对焦虑抑郁样行为及认知的影响:临床前研究的系统综述与荟萃分析
该研究系统综述并荟萃分析了123项动物研究,评估大麻二酚(CBD)对焦虑样、抑郁样行为及认知的影响。结果显示CBD持续减少焦虑样和抑郁样行为,效应量中等;认知改善在逆境、辨别和工作记忆任务中较明显,而在海马依赖性空间记忆测试中小或不一致。机制涉及5-HT1A受体、内源性大麻素调节、抗炎及神经营养通路等。
要点
- CBD持续减少焦虑样和抑郁样行为,在多个行为范式中的效应量中等。
- CBD对认知的影响异质:改善逆境、辨别和工作记忆,对海马依赖性空间记忆效果小或不一致。
- CBD效应常取决于行为测试类型和是否存在基础病理;机制涉及5-HT1A、内源性大麻素等通路。
核心结论
- CBD在多种临床前模型中减少焦虑样和抑郁样行为并改善认知表现,但人类临床证据仍有限且不确定。
研究设计与样本
- 系统综述与荟萃分析,纳入123项评估CBD对焦虑样、抑郁样行为及认知影响的动物研究。
主要发现
- CBD持续减少焦虑样和抑郁样行为,在高架十字迷宫、新奇抑制摄食、强迫游泳、蔗糖偏好和悬尾测试中效应量中等。
- CBD在逆境、辨别和工作记忆任务中改善认知表现,但在海马依赖性空间记忆测试中效应小或不一致。
- 亚组分析显示CBD疗效常取决于行为测试类型和是否存在基础病理。
- 机制证据涉及5-HT1A受体等5-羟色胺能信号、内源性大麻素调节、抗炎和神经营养通路以及线粒体和突触可塑性过程。
- 偏倚风险评估显示研究质量中等至高等,支持结果的稳健性。
临床怎么用
- 临床前证据支持CBD治疗焦虑、抑郁及认知障碍的转化潜力,但人类临床证据有限,尚不足以指导临床决策。
局限性
- 人类临床证据仍有限且不确定,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cannabidiol (CBD) has emerged as a promising neuroprotective compound, with potential benefits for cognitive and emotional behaviors. However, the consistency of its effects across preclinical models remains uncertain. METHODS: We conducted a systematic review and meta-analysis of 123 animal studies assessing the impact of CBD on anxiety-like and depressive-like behaviors, as well as cognition. RESULTS: CBD consistently reduced anxiety- and depressive-like behaviors, with moderate effect sizes observed in paradigms such as the elevated plus maze, novelty suppressed feeding, forced swim, sucrose preference, and tail suspension test. Cognitive effects were more heterogeneous: CBD improved performance in adverse, discriminatory, and working memory tasks, while effects were small or inconsistent in hippocampus-dependent spatial memory tests. Subgroup analyses revealed that CBD's efficacy often depended on the type of behavioral test and the presence of underlying pathologies. Mechanistic evidence implicates serotonergic signaling (notably 5-HT1A receptors), endocannabinoid modulation, anti-inflammatory and neurotrophic pathways, as well as mitochondrial and synaptic plasticity processes, as contributors to these behavioral outcomes. Risk of bias assessment indicated moderate to high quality across studies, confirming the robustness of the findings. CONCLUSIONS: Overall, our results indicate that CBD reduces anxiety-like and depressive-like behaviors and improves cognitive performance across a variety of preclinical models. While these findings support its therapeutic potential and provide a rationale for guiding translational research, clinical evidence in humans is still limited and inconclusive, underscoring the need for further research.
引用
- Jantsch J, Wickert F, Fraga GF, et al. Effects of cannabidiol on anxiety- and depressive-like behaviors and cognition: a systematic review and meta-analysis of preclinical studies. Mol Psychiatry. 2026. PMID: 42380607. doi:10.1038/s41380-026-03733-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。